latest update:
[RxAtlas]

drug summary · 2 NDC codes

LYTGOBI 16 mg/1

FUTIBATINIB

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 46191NDC codes 2application NDA214801RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameFUTIBATINIB
active ingredientsFUTIBATINIB
dosage formTABLET
routeORAL
strength16 mg/1
marketing statusNDA
DEA schedulenot reported
application numberNDA214801
ATC codenot reported
RxCUInot reported
manufacturerTAIHO PHARMACEUTICAL CO., LTD.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA]; Fibroblast Growth Factor Receptor Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
64842-0127—
64842012707—

Other FUTIBATINIB products

One other product in the current release publishes the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.